Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
517
datasets available to search
ShareScore release 0.9.0
Dataset results
517 results for “Checkpoint inhibitors”
A Retrospective Study of Safety and Efficacy of Locoregional Therapies Combined With Anti-VEGF/TKIs and Immune Checkpoint Inhibitors for All Comers of Intention-to-treat Patients With Unresectable Hep
ClinicalTrials.gov study NCT07368023. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Efficacy of Platinum-based Chemotherapy Plus Immune Checkpoint Inhibitors for EGFR/ALK/ROS1 Mutant Lung Cancer
ClinicalTrials.gov study NCT05284539. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Impact of Emotional Disorders on Response to Immune Checkpoint Inhibitor Therapy in Liver Cancer
ClinicalTrials.gov study NCT07325565. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A PD-1 Checkpoint Inhibitor (Cemiplimab) for High-Risk Localized, Locally Recurrent, or Regionally Advanced Skin Cancer
ClinicalTrials.gov study NCT04315701. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Predictive Biomarkers of Response to Checkpoint Inhibitors in Triple Negative Breast Cancer: a Multiomics Platform
ClinicalTrials.gov study NCT05916755. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Checkpoint Inhibitor Combinations Therapy as First Line for HCC Via IT
ClinicalTrials.gov study NCT06482801. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Immune Checkpoint Inhibitors + Chemotherapy Versus Chemotherapy in the Neoadjuvant Treatment of Locally Advanced Colorectal Cancer
ClinicalTrials.gov study NCT06154538. IPD Sharing: NO. Countries: 1. Publications: 0.
POINTING: Clinical Cohort Study of Patients With Melanoma and NSCLC Receiving Checkpoint Inhibitors
ClinicalTrials.gov study NCT04193956. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Immunological Markers Predictive of Response and Toxicity to Checkpoint Inhibitors in Non-small Cell Lung Cancer
ClinicalTrials.gov study NCT04918836. IPD Sharing: YES. Countries: 1. Publications: 0.
A Study of CHeckpoint Inhibitors in Men With prOgressive Metastatic Castrate Resistant Prostate Cancer Characterized by a Mismatch Repair Deficiency or Biallelic CDK12 Inactivation
ClinicalTrials.gov study NCT04104893. IPD Sharing: NO. Countries: 1. Publications: 0.
Immune Related Toxicity and Symptom Burden in Chronic Cancer Survivors With Melanoma Receiving Adjuvant Immunotherapy With Immune Checkpoint Inhibitors
ClinicalTrials.gov study NCT04990726. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Exploring Gut Microbiome Differences in Female Cancer Patients With Varied Ovarian Function and Fertility Outcomes Following Immune Checkpoint Inhibitor Therapy
ClinicalTrials.gov study NCT07201259. IPD Sharing: YES. Countries: 1. Publications: 0.
Sleep and Immune Checkpoint Inhibitors
ClinicalTrials.gov study NCT04070651. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Neoadjuvant Immune Checkpoint Inhibitor Combined With Chemotherapy in Non-small Cell Lung Cancer
ClinicalTrials.gov study NCT04945200. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study of Camrelizumab Combined Apatinib in Hepatocellular Carcinoma Previously Treated With Immune Checkpoint Inhibitors (ICIs).
ClinicalTrials.gov study NCT04826406. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Immune Checkpoint Inhibitors Rechallenge After Immune-related Adverse Events
ClinicalTrials.gov study NCT04169503. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Pilot Study of Blood-based Biomarkers for Response to Immune Checkpoint Inhibitors
ClinicalTrials.gov study NCT06630429. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Safety and Modulation of Adaptive Immunity by Iscador® Qu Viscum Album Extract in Patients With Advanced, Recurrent or Metastatic Cancers Treated With Immune Checkpoint Inhibitors
ClinicalTrials.gov study NCT06408688. IPD Sharing: NO. Countries: 1. Publications: 0.
Prognostic Impact of Cardiac Imaging During Suspected Immune Checkpoint Inhibitor Myocarditis
ClinicalTrials.gov study NCT05086146. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Autoimmune Endocrine Disease Related Antibodies Before the Start of Immune Checkpoint Inhibitor Therapy
ClinicalTrials.gov study NCT06993727. IPD Sharing: NO. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.